Acute Hypertensive Cerebral Hemmorrhage Surgery

NCT04957849 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2021-07-12

No results posted yet for this study

Summary

The Neuroendoscopic, Trans-occipital Approach Evacuation of Acute Hypertensive Cerebral Hemmorrhage Combined Low-drainage Surgery: a Multi-center Clinical Trial

Conditions

  • Hypertensive Intracerebral Hemorrhage

Interventions

PROCEDURE

The Neuroendoscopic, Trans-occipital Approach Evacuation of Acute Hypertensive Cerebral Hemmorrhage Combined Low-drainage Surgery

The Neuroendoscopic, Trans-occipital Approach Evacuation of Acute Hypertensive Cerebral Hemmorrhage Combined Low-drainage Surgery

PROCEDURE

Endoscopic Evacuation of Acute Hypertensive Intracerebral Hemorrhage via Trans-frontal keyhole approach

Endoscopic Evacuation of Acute Hypertensive Intracerebral Hemorrhage via Trans-frontal keyhole approach

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER
  • Huashan Hospital

    collaborator OTHER
  • Tianjin Medical University General Hospital

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Peking Union Medical College Hospital

    collaborator OTHER
  • Second Affiliated Hospital of Soochow University

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • The General Hospital of Eastern Theater Command

    collaborator OTHER
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • ShuGuang Hospital

    collaborator OTHER
  • Qianfoshan Hospital

    collaborator OTHER
  • Shanghai Changzheng Hospital

    lead OTHER

Principal Investigators

  • Lijun Hou, MD,PhD · Shanghai Changzheng Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-12-31
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04957849 on ClinicalTrials.gov